Next, we further explored whether B7H3-IL7Rα CAR-T cells had functional advantages in terms of antitumor activity and T-cell proliferation over conventional B7H3 CAR-T cells using an in vitro tumor-rechallenge assay. This evidence concerns the gene IL7R and neoplasm.